These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34634562)

  • 1. Symptom networks in patients with substance use disorders.
    Rutten RJT; Broekman TG; Schippers GM; Schellekens AFA
    Drug Alcohol Depend; 2021 Dec; 229(Pt B):109080. PubMed ID: 34634562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The centrality of craving in network analysis of five substance use disorders.
    Gauld C; Baillet E; Micoulaud-Franchi JA; Kervran C; Serre F; Auriacombe M
    Drug Alcohol Depend; 2023 Apr; 245():109828. PubMed ID: 36868091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test-retest reliability of DSM-5 substance disorder measures as assessed with the PRISM-5, a clinician-administered diagnostic interview.
    Hasin D; Shmulewitz D; Stohl M; Greenstein E; Roncone S; Aharonovich E; Wall M
    Drug Alcohol Depend; 2020 Nov; 216():108294. PubMed ID: 33007702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agreement between DSM-5 and DSM-IV measures of substance use disorders in a sample of adult substance users.
    Livne O; Shmulewitz D; Stohl M; Mannes Z; Aharonovich E; Hasin D
    Drug Alcohol Depend; 2021 Oct; 227():108958. PubMed ID: 34450471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of the DSM-5 craving criterion for alcohol, tobacco, cannabis, cocaine, heroin, and non-prescription use of prescription painkillers (opioids).
    Shmulewitz D; Stohl M; Greenstein E; Roncone S; Walsh C; Aharonovich E; Wall MM; Hasin DS
    Psychol Med; 2023 Apr; 53(5):1955-1969. PubMed ID: 35506791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Item Response Theory analyses of DSM-5 substance use disorder criteria in French outpatient addiction clinic participants. How much is craving special?
    Kervran C; Shmulewitz D; Serre F; Stohl M; Denis C; Hasin D; Auriacombe M
    Drug Alcohol Depend; 2020 Jul; 212():108036. PubMed ID: 32464467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network analysis of substance abuse and dependence symptoms.
    Rhemtulla M; Fried EI; Aggen SH; Tuerlinckx F; Kendler KS; Borsboom D
    Drug Alcohol Depend; 2016 Apr; 161():230-7. PubMed ID: 26898186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commonalities and Differences Across Substance Use Disorders: Phenomenological and Epidemiological Aspects.
    Shmulewitz D; Greene ER; Hasin D
    Alcohol Clin Exp Res; 2015 Oct; 39(10):1878-900. PubMed ID: 26332166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification and short-term course of DSM-IV cannabis, hallucinogen, cocaine, and opioid disorders in treated adolescents.
    Chung T; Martin CS
    J Consult Clin Psychol; 2005 Dec; 73(6):995-1004. PubMed ID: 16392973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of DSM-IV and DSM-5 alcohol, cocaine, opioid, and cannabis use disorders in a largely substance dependent sample.
    Peer K; Rennert L; Lynch KG; Farrer L; Gelernter J; Kranzler HR
    Drug Alcohol Depend; 2013 Jan; 127(1-3):215-9. PubMed ID: 22884164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbid mental disorders in substance users from a single catchment area--a clinical study.
    Langås AM; Malt UF; Opjordsmoen S
    BMC Psychiatry; 2011 Feb; 11():25. PubMed ID: 21314980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward more efficient diagnostic criteria sets and rules: The use of optimization approaches in addiction science.
    Stevens JE; Steinley D; McDowell YE; Boness CL; Trull TJ; Martin CS; Sher KJ
    Addict Behav; 2019 Jul; 94():57-64. PubMed ID: 30777336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD-11 and other classification systems: analysis of data from the WHO's World Mental Health Surveys.
    Degenhardt L; Bharat C; Bruno R; Glantz MD; Sampson NA; Lago L; Aguilar-Gaxiola S; Alonso J; Andrade LH; Bunting B; Caldas-de-Almeida JM; Cia AH; Gureje O; Karam EG; Khalaf M; McGrath JJ; Moskalewicz J; Lee S; Mneimneh Z; Navarro-Mateu F; Sasu CC; Scott K; Torres Y; Poznyak V; Chatterji S; Kessler RC;
    Addiction; 2019 Mar; 114(3):534-552. PubMed ID: 30370636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Greater Prevalence of Proposed ICD-11 Alcohol and Cannabis Dependence Compared to ICD-10, DSM-IV, and DSM-5 in Treated Adolescents.
    Chung T; Cornelius J; Clark D; Martin C
    Alcohol Clin Exp Res; 2017 Sep; 41(9):1584-1592. PubMed ID: 28667763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Incidence of Signs of Neuropathy and Self-Reported Substance Use Disorder for Nitrous Oxide in Patients Intoxicated with Nitrous Oxide.
    Nugteren-Van Lonkhuyzen JJ; van der Ben L; van den Hengel-Koot IS; de Lange DW; van Riel AJHP; Hondebrink L
    Eur Addict Res; 2023; 29(3):202-212. PubMed ID: 37100039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric modeling of abuse and dependence symptoms across six illicit substances indicates novel dimensions of misuse.
    Clark SL; Gillespie NA; Adkins DE; Kendler KS; Neale MC
    Addict Behav; 2016 Feb; 53():132-40. PubMed ID: 26517709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids.
    Gillespie NA; Neale MC; Prescott CA; Aggen SH; Kendler KS
    Addiction; 2007 Jun; 102(6):920-30. PubMed ID: 17523987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network Analysis of DSM Symptoms of Substance Use Disorders and Frequently Co-Occurring Mental Disorders in Patients with Substance Use Disorder Who Seek Treatment.
    López-Toro E; Wolf CJH; González RA; van den Brink W; Schellekens A; Vélez-Pastrana MC; On Behalf Of The Afp Working Collaborative Group
    J Clin Med; 2022 May; 11(10):. PubMed ID: 35629008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance use problems and associated psychiatric symptoms among adolescents in primary care.
    Shrier LA; Harris SK; Kurland M; Knight JR
    Pediatrics; 2003 Jun; 111(6 Pt 1):e699-705. PubMed ID: 12777588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Addictive behaviours from DSM-IV to DSM-5].
    van den Brink W
    Tijdschr Psychiatr; 2014; 56(3):206-10. PubMed ID: 24643833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.